Thursday, March 14, 2024

๐ŸŒŽ Maplebear Upgraded, Citigroup Upgraded, Integer Initiated and more...

Ratings changes for TRACON Pharmaceuticals, Hello Group, Natera, Tempest Therapeutics, Adicet Bio, Maplebear, Ironwood Pharmaceuticals and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
March 14th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Ashland (NYSE:ASH) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $126.00 price target on the stock, up previously from $100.00. This represents a 32.1% upside from the current price of $95.37.
  • Citigroup (NYSE:C) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $68.00 price target on the stock. This represents a 19.0% upside from the current price of $57.13.
  • Maplebear (NASDAQ:CART) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating. They now have a $43.00 price target on the stock, up previously from $30.00. This represents a 20.9% upside from the current price of $35.58.
  • The Goldman Sachs Group (NYSE:GS) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to an "outperform" rating. They now have a $430.00 price target on the stock, up previously from $410.00. This represents a 10.4% upside from the current price of $389.32.
  • Jack in the Box (NASDAQ:JACK) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $88.00 price target on the stock, up previously from $79.00. This represents a 21.3% upside from the current price of $72.52.
  • Marathon Oil (NYSE:MRO) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $31.00 price target on the stock. This represents a 19.1% upside from the current price of $26.02.
  • NewLake Capital Partners (OTCMKTS:NLCP) was upgraded by analysts at Compass Point from a "neutral" rating to a "buy" rating. They now have a $18.25 price target on the stock. This represents a 10.9% upside from the current price of $16.45.
  • NeuroPace (NASDAQ:NPCE) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $16.00. This represents a 43.7% upside from the current price of $13.92.
  • Oracle (NYSE:ORCL) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.The current price is $126.17.
  • UiPath (NYSE:PATH) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $28.00 price target on the stock, up previously from $22.00. This represents a 24.9% upside from the current price of $22.42.
  • Palomar (NASDAQ:PLMR) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $88.00 price target on the stock, up previously from $78.00. This represents a 6.5% upside from the current price of $82.65.
  • RTX (NYSE:RTX) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $120.00 price target on the stock, up previously from $100.00. This represents a 30.2% upside from the current price of $92.16.
  • Solid Biosciences (NASDAQ:SLDB) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $8.00. This represents a 60.6% upside from the current price of $12.45.
  • Thomson Reuters (NYSE:TRI) (TSE:TRI) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $180.00 price target on the stock, up previously from $150.00. This represents a 15.9% upside from the current price of $155.26.
  • Utz Brands (NYSE:UTZ) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $22.00 price target on the stock, up previously from $19.00. This represents a 22.2% upside from the current price of $18.00.
  • Williams-Sonoma (NYSE:WSM) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $270.00 price target on the stock, up previously from $155.00. This represents a 4.3% downside from the current price of $282.25.
  • Williams-Sonoma (NYSE:WSM) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $263.00 price target on the stock, up previously from $154.00. This represents a 6.8% downside from the current price of $282.25.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Haynes International (NASDAQ:HAYN) was downgraded by analysts at Northcoast Research from a "buy" rating to a "neutral" rating.The current price is $59.35.
  • Oportun Financial (NASDAQ:OPRT) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $3.50 price target on the stock, down previously from $9.00. This represents a 1.1% downside from the current price of $3.54.
  • Paymentus (NYSE:PAY) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $23.82.
  • Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating.The current price is $1.10.
  • Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $2.00 price target on the stock, down previously from $9.00. This represents a 81.8% upside from the current price of $1.10.
  • Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at SVB Leerink LLC from an "outperform" rating to a "market perform" rating. They now have a $2.00 price target on the stock, down previously from $9.00. This represents a 81.8% upside from the current price of $1.10.
  • Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $1.10.
  • Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.The current price is $1.10.
  • UGI (NYSE:UGI) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $28.00 price target on the stock, up previously from $27.00. This represents a 14.7% upside from the current price of $24.41.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Absci (NASDAQ:ABSI) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $13.00 price target on the stock. This represents a 172.0% upside from the current price of $4.78.
  • AECOM (NYSE:ACM) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $106.00 price target on the stock. This represents a 16.1% upside from the current price of $91.27.
  • Atlas Energy Solutions (NYSE:AESI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $24.00 price target on the stock. This represents a 10.2% upside from the current price of $21.78.
  • AGCO (NYSE:AGCO) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $142.00 price target on the stock. This represents a 21.9% upside from the current price of $116.47.
  • American Healthcare REIT (NYSE:AHR) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 30.5% upside from the current price of $13.79.
  • Alcon (NYSE:ALC) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating on the stock.The current price is $86.91.
  • AMETEK (NYSE:AME) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $210.00 price target on the stock. This represents a 16.0% upside from the current price of $180.97.
  • Amkor Technology (NASDAQ:AMKR) is now covered by analysts at Fox Advisors. They set an "equal weight" rating on the stock.The current price is $31.79.
  • Bitdeer Technologies Group (NASDAQ:BTDR) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $13.00 price target on the stock. This represents a 108.3% upside from the current price of $6.24.
  • Caterpillar (NYSE:CAT) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $390.00 price target on the stock. This represents a 14.2% upside from the current price of $341.38.
  • Cognex (NASDAQ:CGNX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $47.00 price target on the stock. This represents a 14.0% upside from the current price of $41.21.
  • Cummins (NYSE:CMI) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $303.00 price target on the stock. This represents a 13.7% upside from the current price of $266.38.
  • Conduent (NASDAQ:CNDT) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $9.00 price target on the stock. This represents a 183.9% upside from the current price of $3.17.
  • CNH Industrial (NYSE:CNHI) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $18.00 price target on the stock. This represents a 45.6% upside from the current price of $12.36.
  • Catalyst Pharmaceuticals (NASDAQ:CPRX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $27.00 price target on the stock. This represents a 65.8% upside from the current price of $16.28.
  • Deere & Company (NYSE:DE) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $494.00 price target on the stock. This represents a 30.7% upside from the current price of $378.01.
  • Fluor (NYSE:FLR) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $46.00 price target on the stock. This represents a 18.5% upside from the current price of $38.81.
  • Fortive (NYSE:FTV) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $99.00 price target on the stock. This represents a 16.3% upside from the current price of $85.12.
  • Robinhood Markets (NASDAQ:HOOD) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 63.3% upside from the current price of $18.37.
  • Integer (NYSE:ITGR) is now covered by analysts at CL King. They set a "buy" rating and a $137.00 price target on the stock. This represents a 20.6% upside from the current price of $113.56.
  • Illinois Tool Works (NYSE:ITW) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $301.00 price target on the stock. This represents a 13.6% upside from the current price of $265.08.
  • Jacobs Solutions (NYSE:J) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $154.00 price target on the stock. This represents a 3.3% upside from the current price of $149.06.
  • MasTec (NYSE:MTZ) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $96.00 price target on the stock. This represents a 13.1% upside from the current price of $84.88.
  • NewAmsterdam Pharma (NASDAQ:NAMS) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock. This represents a 59.8% upside from the current price of $21.90.
  • Oshkosh (NYSE:OSK) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $121.00 price target on the stock. This represents a 5.9% upside from the current price of $114.30.
  • PACCAR (NASDAQ:PCAR) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $117.00 price target on the stock. This represents a 2.4% upside from the current price of $114.24.
  • Parker-Hannifin (NYSE:PH) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $602.00 price target on the stock. This represents a 12.2% upside from the current price of $536.74.
  • Quanta Services (NYSE:PWR) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $301.00 price target on the stock. This represents a 24.9% upside from the current price of $241.08.
  • Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $60.00 price target on the stock. This represents a 141.0% upside from the current price of $24.90.
  • Sirius XM (NASDAQ:SIRI) is now covered by analysts at Guggenheim. They set a "neutral" rating and a $4.00 price target on the stock. This represents a 1.7% downside from the current price of $4.07.
  • Terex (NYSE:TEX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $73.00 price target on the stock. This represents a 26.5% upside from the current price of $57.72.
  • Tempest Therapeutics (NASDAQ:TPST) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $13.00 price target on the stock. This represents a 261.1% upside from the current price of $3.60.
  • United Rentals (NYSE:URI) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $793.00 price target on the stock. This represents a 18.4% upside from the current price of $669.92.
  • Zebra Technologies (NASDAQ:ZBRA) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $300.00 price target on the stock. This represents a 6.5% upside from the current price of $281.64.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: my top trade on these 9 tickers

No comments:

Post a Comment

22 spring outfit ideas to fight fashion-decision fatigue

Your Horoscope For The Week Of May 13 VIEW IN BROWSER ...